Here is an old 2016 R&R report estimate, still good reading. They estimated that a little over 1B peak sales with 30k price with combo. Also I will look up cydy independent report last year, I might still have it. After the BLA submission, we should get new potential investors finding out about leronlimab asking these same questions.

For mine, I was being conservative with market, just for investment purposes, R5 at 50%, unknown mdr2+ vs mdr2. I’m guessing from the Samsung deal, cydy’s low end estimate is 10000 for 2020.

https://hcwco.bluematrix.com/sellside/EmailDo...p;mime=pdf